DE vs TMO: Which Is the Better Buy?
Side-by-side comparison of Deere & Company and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-06-20.
Deere & Company · Industrials
$589.24
-29.6% upside to fair value
Grade D
High Quality
VS
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
TMO has more upside to fair value
(+7.2%).
TMO trades at a lower forward P/E
(25.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DE |
TMO |
| Current Price |
$589.24 |
$464.61 |
| Fair Value Estimate |
$414.61 |
$498.27 |
| Upside to Fair Value |
-29.6%
|
+7.2%
|
| Market Cap |
$159.1B |
$172.7B |
| Forward P/E |
33.3x
|
25.2x
|
| EV / EBITDA |
18.8x
|
19.1x
|
| Price / Sales |
3.4x
|
3.8x
|
| Price / FCF |
42.2x
|
25.6x
|
| Revenue Growth YoY |
+6.7%
|
+6.2%
|
| Gross Margin |
35.4%
|
39.4%
|
| Operating Margin |
18.4%
|
17.8%
|
| Return on Equity |
18.3%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
2.37%
|
3.91%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Deere & Company is a leading global manufacturer of agricultural, construction, and forestry machinery with a durable competitive moat anchored by its number one market share in large agricultural equipment and a dense dealer network. The company benefits from embedded precision agriculture technology that widens its competitive gap, particularly in North America where it holds 40 to 60 percent m…
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Accumulation Zones
| Metric |
DE |
TMO |
| Zone Low |
$310.96 |
$373.70 |
| Zone High |
$352.42 |
$423.53 |
| In Buy Zone? |
No
|
No
|